Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam in Amnestic Mild Cognitive Impairment
NCT01044758Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- Dec 2009
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of levetiracetam in amnestic mild cognitive impairment (MCI), sponsored by Johns Hopkins University. Started Dec 2009; status: completed.
02
Drugs
levetiracetam
03
Conditions
amnestic mild cognitive impairment (MCI)
Beyond the preview
Go deeper on NCT01044758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01044758.